how many chemo treatments for stage 1 breast cancer

Suggested questions for stage 1

Suggested questions for stage 1

Ngày tải lên : 05/10/2013, 08:48
... interesting building in Guangzhou? Suggested topics in stage 2 & related questions for stage 3 Category 1: Describing things (1 test item) 1. Describing a piece of equipment you often use at ... Suggestedquestionsforstage 1 Warm-up 1. Could you show me your identification card please? 2. Could you tell me your full name please? 3. ... wor k. You should say, What is it ? What you do with it/ How to use it? How long you have had it? How important it is to you? Discussion: 1. What are the impacts of electrical equipment on human’s...
  • 10
  • 601
  • 0
Tài liệu Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study pdf

Tài liệu Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study pdf

Ngày tải lên : 15/02/2014, 04:20
... 2.03 0 .11 11 9.62 ജ50 y old 5 16 0. 31 1.00 3 .19 1. 12 11 .15 Deep vein thrombosis‡ 22 35 0.84 1. 34 1. 60 0. 91 2.86 ഛ49 y old 8 11 0.78 1. 08 1. 39 0. 51 3.99 ജ50 y old 14 24 0.88 1. 51 1. 71 0.85–3.58 *Seven ... 0.55 0.25 1. 15 Spine 31 23 1. 18 0.88 0.74 0. 41 1. 32 Radius, Colles’ 23 14 0.88 0.54 0. 61 0.29 1. 23 Other lower radius* 63 66 2. 41 2.54 1. 05 0.73 1. 51 Total 13 7† 11 1‡ 5.28 4.29 0. 81 0.63 1. 05 ഛ49 ... 23 3 10 .11 1. 43 0 .14 0.03–0.47 5-y predicted breast cancer risk, % ഛ2.00 35 13 5.54 2.06 0.37 0 .18 –0.72 2. 01 3.00 42 29 5 .18 3. 51 0.68 0. 41 1. 11 3. 01 5.00 43 27 5.88 3.88 0.66 0.39 1. 09 ജ5. 01 55...
  • 18
  • 645
  • 0
báo cáo hóa học: " Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and " potx

báo cáo hóa học: " Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and " potx

Ngày tải lên : 21/06/2014, 01:20
... tumours. Eur J Cancer 2004, 40(9) :13 73 -13 82. doi :10 .11 86/ 219 1- 219 X -1- 20 Cite this article as: Rousseau et al.: Syndecan -1 antigen, a promising new target for triple-negative breast cancer immuno-PET ... MDA-MB-468 xenograft tumors. EJNMMI Research 2 011 1: 20. Rousseau et al. EJNMMI Research 2 011 , 1: 20 http://www.ejnmmires.com/content /1/ 1/20 Page 11 of 11 37 MBq 13 1 I-labeled B-B4 mAb. In the 25.9-MBq ... negative early -stage breast cancer. J Clin Oncol 2006, 24(36):5652-5657. 11 . Oakman C, Viale G, Di Leo A: Management of triple negative breast cancer. Breast 2 010 , 19 (5): 312 - 21. 12 . Irvin WJ Jr,...
  • 11
  • 326
  • 0
Guidelines for management of breast cancer ppt

Guidelines for management of breast cancer ppt

Ngày tải lên : 28/03/2014, 23:20
... research tools. Stage grouping Stage 0: Tis, N0, M0 Stage I: T1, N0, M0 Stage IIa: T0, N1, M0 T1, N1, M0 T2, N0, M0 Stage IIb: T2, N1, M0 T3, N0, M0 Stage IIIa: T0, N2, M0 T1, N2, M0 T2, ... of special problems in breast cancer 37 Figure 13 . Paget’s disease of the nipple-areola complex Figure 14 . Cancer of the male breast: diagnosis Diagnosis of breast cancer 15 Prognostic factors Several ... treatment of early stage invasive breast cancer including surgery, adjuvant therapy for node- negative and node-positive breast cancer, primary chemotherapy in locally-advanced breast cancer, the definitions...
  • 57
  • 423
  • 0
Báo cáo hóa học: "Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival" ppt

Báo cáo hóa học: "Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival" ppt

Ngày tải lên : 18/06/2014, 16:20
... 1. 0 67.4 1. 0 1. 56 - 1. 75 14 8 56.4 1. 9 (1. 1, 3.6) 0.03 39.9 2 .1 (1. 2, 3.6) 0.008 > ;1. 75 90 25.0 3.5 (1. 9, 6.4) < 0.0 01 14.2 3.6 (2 .1, 6 .1) < 0.0 01 Age ≤ 55 years 78 82 .1 1.0 82 .1 1.0 >55 ... 2 .1 (1. 1, 3.7) 0. 01 1.7 (1. 1, 3.0) 0.047 Lymph node status Negative 1. 0 1. 0 Positive 3 .1 (1. 9, 5 .1) < 0.0 01 2.6 (1. 7, 4 .1) < 0.0 01 Estrogen-receptor status Positive 1. 0 1. 0 Negative 1. 6 ... 0.0 01 Age ≤ 55 years 1. 0 1. 0 >55 years 1. 8 (0.8, 4.2) 0 .14 2.7 (1. 2, 5.9) 0. 01 Size of tumour ≤ 2 cm 1. 0 1. 0 >2 cm 1. 0 (0.6, 1. 6) 0.96 1. 0 (0.7, 1. 6) 0.88 Grade of tumour 1 & 2 1. 0 1. 0 3...
  • 10
  • 490
  • 0
Báo cáo khoa học: " SemiCytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer a prospective pilot study" ppt

Báo cáo khoa học: " SemiCytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer a prospective pilot study" ppt

Ngày tải lên : 09/08/2014, 08:22
... interleukins-1b, -4, -6, -8, -10 , and tumor necrosis factors-a, -b: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol 2008, 13 4:8 21- 832. doi :10 .11 86 /17 48- 717 X-5 -16 Cite ... % Surgery No 11 73.3 Yes 4 26.7 Radiotherapy Total tumor dose, Gy 60 2 13 .3 66 2 13 .3 70 10 66.7 72 1 6.7 RT Technique 2D 3 20 3D 10 66.7 IMRT 2 13 .3 Parotid sparing No 13 86.7 Yes 2 13 .3 RT interruptions Yes ... Engl J Med 2004, 350 :19 45 -19 52. 13 . Cooper JS, Bernier J: Rationale for triage in the postoperative management of head and neck cancers. Oncology 2005, 19 :10 11- 1 017 . 14 . Vissink A, Jansma J, Spijkervet...
  • 7
  • 341
  • 0
 Báo cáo y học: "PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers"

Báo cáo y học: "PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers"

Ngày tải lên : 31/10/2012, 16:57
... a potent PARP -1 inhibitor, AG143 61, on BRCA1 mutant and control cancer cells. (A) Clonogenic survival assay. Five hundred 780 (BRCA1 11 / 11 ), and 525 (BRCA1-/-), and NEU (BRCA1+/+) cells were ... human breast cancer cells using three PARP inhibitors: AG143 61, NU1025, and 3- aminobenzamide (3AB) [36]. We first tested a BRCA1 mutant ES cell line [BRCA1 trEx 11/ Δ 11 that carries one BRCA1 ... breast cancer cell lines: MCF-7 (BRCA1+/+), MDA-MB-2 31 (BRCA1+/-), HCC1937 (BRCA1-/-) and SUM1 315 MO2 (BRCA1-/-). Using both clonogenic survival assay and MTT assay, we found that PARP -1 inhibitors...
  • 7
  • 415
  • 0
VIDEO FOR BUSINESS 1 HOW TO COMMISSION A VIDEO pot

VIDEO FOR BUSINESS 1 HOW TO COMMISSION A VIDEO pot

Ngày tải lên : 09/03/2014, 02:20
... Draft. Chpater 10 - Ways of Delivering your Video. Chapter 11 - Maximising your Finished Film. Chapter 12 - Where to next. About the Author. ooOoo Chapter 1 Why This is the Book for You You need ... (if less than 10 00) and replication (for 10 00 or more) Most video firms will arrange all this for you. If you are planning web or social media video the encoding and uploading for this will ... such as DSLRs for certain effects, tripods (not worth having under 10 00/ $15 00) lighting of various kinds, perhaps about 1, 500, a suitable vehicle, edit suites and extra hard drives for backing-up...
  • 13
  • 446
  • 0
Báo cáo khoa học: "How Many Words is a Picture Worth? Automatic Caption Generation for News Images" docx

Báo cáo khoa học: "How Many Words is a Picture Worth? Automatic Caption Generation for News Images" docx

Ngày tải lên : 30/03/2014, 21:20
... 2 .12 † 21. 0 Word Overlap 2.46 ∗† 24.3 Cosine 2.26 † 22.0 KL Divergence 1. 77 ∗† 18 .4 JS Divergence 1. 77 ∗† 18 .6 Abstract Words 1. 11 ∗† 10 .0 Abstract Phrases 1. 06 ∗† 10 .1 Table 2: TER results for ... pages 12 39 12 49, Uppsala, Sweden, 11 -16 July 2 010 . c 2 010 Association for Computational Linguistics How Many Words is a Picture Worth? Automatic Caption Generation for News Images Yansong Feng and ... probabilities into equation (12 ), the caption generation model becomes: P(ρ 1 , ρ 2 , , ρ m ) ≈ m ∏ j =1 P(ρ j ∈ C|ρ j ∈ D) (15 ) · m ∏ j=2 P(ρ j |ρ j 1 ) ·P(len(C) = ∑ m j =1 len(ρ j )) · ∏ m ∑ j =1 len(ρ j ) i=3 P adap (w i |w i 1 ,...
  • 11
  • 464
  • 0
Guideline for Management of the Clinical Stage 1 Renal Mass pptx

Guideline for Management of the Clinical Stage 1 Renal Mass pptx

Ngày tải lên : 31/03/2014, 13:20
... Cryo 15 3.5 2.2 5.6 67.0 / 66/7 2.6 / 2.6 LPN RFA 19 1. 6 0.9 3.0 68.9 / 70.2 2.7 / 2.7 Cryo Cryo LPN 24 3.9 3.0 5 .1 60.4 / 60 .1 2.6 / 2.6 LRN LRN OPN 11 0.5 0.2 1. 2 59 .1 / 59.0 3 .1 / 3 .1 ... Cryo 10 87.6 80.9 92.2 67.0 / 66.5 2.5 / 2.6 26.2 / 18 .3 RFA 10 85.2 81. 3 88.5 67.6 / 70.0 2.8 / 2.7 39.3 / 32.8 LPN 17 98.3 97.0 99.0 61. 2 / 61. 0 2.6 / 2.6 25.8 / 16 .0 OPN 21 95 .1 93.6 ... Oncol 19 99; 17 : 523. 70. Nanus DM, Garino A, Milowsky MI, and et al: Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma. Cancer 2004; 10 1: 15 45. 71. Leibovich...
  • 81
  • 446
  • 0
Báo cáo khoa học: " Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity" potx

Báo cáo khoa học: " Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity" potx

Ngày tải lên : 09/08/2014, 09:20
... toxicity Toxicity No (%) V 10 0 (cm 3 ) P ‡ V 15 0 (cm 3 ) P ‡ DHI P ‡ Skin Yes* 11 (22.9) 51. 3 ± 12 .1 0.2 21 25.7 ± 6.2 0.222 0. 51 ± 0.03 0 .10 5 No 37 (77 .1) 43.0 ± 18 .9 22.0 ± 8.7 0.49 ± 0.03 Subcutaneous ... Harris JR: Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 19 85, 11 :12 71- 1276. 13 . Harris ... with radical mastectomy for early breast cancer. N Engl J Med 2002, 347 :12 27 -12 32. 6. Morrow M: Rational local therapy for breast cancer. N Engl J Med 2002, 347 :12 70 -12 71. 7. Clarke M, Collins...
  • 8
  • 339
  • 0